RLMD in the 13F filings
Relmada Therapeutics Inc · CUSIP 75955J402
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 18 May 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 16
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 1 listed it in both
- Shares listed
- 23,377,289
- combined, among listed positions
- Reported value
- $163m
- combined, at the quarter end
Among the 91 comparable managers: 11 buyers (opened or added shares) and 7 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +8,293,133.
Managers listing RLMD in Q1 2026
16 of 16 holders
Largest increases and reductions, by shares
Increases
- Janus Henderson Group Ltdexisting position · 11,063,862 shares now+3,793,862
- Millennium Management LLCexisting position · 3,907,265 shares now+2,234,248
- Marshall Wace LLPexisting position · 4,481,606 shares now+1,291,944
- Susquehanna International Group LLPexisting position · 1,011,572 shares now+625,630
- Woodline Partners LPnew position · 421,052 shares now+421,052
Reductions
- Balyasny Asset Management LLCexisting position · 252,457 shares now-295,397
- Two Sigma Investments LPexisting position · 408,095 shares now-164,740
- Squarepoint Ops LLCexisting position · 63,426 shares now-74,807
- Jane Street Group LLCexisting position · 221,969 shares now-49,140
- Renaissance Technologies LLCexisting position · 167,200 shares now-17,800
New positions and exits
New (3)
Exited (2)
- ExodusPoint Capital Management LPwas $333k
- Citadel Advisors LLCwas $136k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2019 | 1 | $5.3m | n.a. | n.a. |
| Q1 2020 | 1 | $964k | n.a. | n.a. |
| Q2 2020 | 1 | $7.4m | n.a. | n.a. |
| Q3 2020 | 1 | $7.5m | n.a. | n.a. |
| Q4 2020 | 1 | $9.1m | n.a. | n.a. |
| Q4 2021 | 1 | $21m | n.a. | n.a. |
| Q1 2022 | 2 | $39m | n.a. | n.a. |
| Q2 2022 | 2 | $26m | n.a. | n.a. |
| Q3 2022 | 2 | $37m | n.a. | n.a. |
| Q4 2023 | 1 | $4.9m | 1 | 0 |
| Q1 2024 | 1 | $5.5m | 0 | 1 |
| Q4 2025 | 1 | $35m | 15 | 1 |
| Q1 2026 | 1 | $77m | 11 | 7 |
| Q2 2026 | 1 | $77m | 10 | 13 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
RLMD and LLY →RLMD and JNJ →RLMD and VRTX →Choose a stock to compare with RLMD →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own RLMD, latest filings →Back to the 13F Explorer →